Editorial: The expanding spectrum of hemophagocytic lymphohistiocytosis: pathogenic mechanisms and therapeutic implications 21 de October de 2026 by Tiziana Lorenzini
Editorial: Liver diseases – from pathophysiology to new treatment options 20 de October de 2026 by Theodoros Androutsakos
Editorial: Predictive biomarkers to immune checkpoint inhibitors in lung cancer 20 de October de 2026 by Alessandro Russo
Editorial: Sharpen the tools to decipher cell-cell communication better 20 de October de 2026 by Qingfei Pan
Editorial: Lipid-immune interplay in chronic inflammatory-based disorders 19 de October de 2026 by Paola De Cicco
Editorial: The differentiation and reprogramming of tumor-associated myeloid cells and therapeutic strategies for cancer immunotherapy 16 de October de 2026 by Paul Takam Kamga
Editorial: Immunology of human fungal pathogens: host-pathogen interactions, immune evasion, and therapeutic strategies 14 de October de 2026 by Iván Martínez-Duncker
Editorial: Community series in unveiling the next generation of cancer immunity & immunotherapy in lung cancer, volume II 13 de October de 2026 by Nethaji Muniraj
Editorial: Beyond conventional biomarkers: unlocking immunotherapy response through novel biomarkers or combinatorial approaches 13 de October de 2026 by Ünal Metin Tokat
